Recent Updates
Recently added Catalysts
HCM Positive Sentiment Score: 75/100

Vesting of awards under the Long Term Incentive Plan Hong Kong, Shanghai & Florham Park, NJ - Wednesday

Key Takeaway: HUTCHMED (China) Limited has announced the successful vesting of awards under its Long Term Incentive Plan for two executive directors, Dr. Weiguo Su and Mr. Johnny Cheng, on March 10, 2026. The awards, which included a total of 726,317 ordinary shares, were granted on June 5, 2023. This vesting followed the company's announcement of its 2025 annual results on March 5, 2026, and serves to align the interests of the executive team with those of the shareholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Successful vesting of a significant number of shares for key executives.
  • Demonstrates commitment to the Long Term Incentive Plan.
  • Strengthens leadership alignment with shareholder interests.

Full Press Release Details

Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ - Wednesday, March 11, 2026: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) announces that following the announcement of the 2025 annual results of HUTCHMED on March 5, 2026, the following awards granted under the Long Term Incentive Plan ("LTIP") on June 5, 2023 to Dr Weiguo Su and Mr Johnny Cheng were vested on March 10, 2026:-
Award Holders Number of ordinary shares
Person Discharging Managerial Responsibilities
Dr Weiguo Su (Executive Director, Chief Executive Officer and Chief Scientific Officer) 524,079
Mr Johnny Cheng (Executive Director, Acting Chief Executive Officer and Chief Financial Officer) 202,238
Total 726,317
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Weiguo Su
2 Reason for the notification
a) Position/status Executive Director, Chief Executive Officer and Chief Scientific Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name HUTCHMED (China) Limited
b) LEI 2138006X34YDQ6OBYE79
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary Shares of US$0.10 Ordinary Share with DI ISIN: KYG4672N1016
b) Nature of the transaction Vesting of awards granted on June 5, 2023 under HUTCHMED's LTIP
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 524,079 ordinary shares
d) Aggregated information - Aggregated volume - Price N/A
e) Date of the transaction 2026-03-10
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Johnny Cheng
2 Reason for the notification
a) Position/status Executive Director, Acting Chief Executive Officer and Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name HUTCHMED (China) Limited
b) LEI 2138006X34YDQ6OBYE79
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary Shares of US$0.10 Ordinary Share with DI ISIN: KYG4672N1016
b) Nature of the transaction Vesting of awards granted on June 5, 2023 under HUTCHMED's LTIP
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 202,238 ordinary shares
d) Aggregated information - Aggregated volume - Price N/A
e) Date of the transaction 2026-03-10
f) Place of the transaction Outside a trading venue
Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting - +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Tim Stamper +44 7771 913 902 (Mobile) / +44 7779 436 698 (Mobile)
Brunswick - Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500
Deutsche Numis Joint Broker
Freddie Barnfield / Jeffrey Wong / Duncan Monteith +44 20 7260 1000

Frequently Asked Questions

Who received awards under HUTCHMED's Long Term Incentive Plan?

Dr. Weiguo Su and Mr. Johnny Cheng were awarded shares under the LTIP.

When were the HUTCHMED awards vested?

The awards were vested on March 10, 2026.

How many shares did Dr. Weiguo Su receive?

Dr. Weiguo Su received 524,079 ordinary shares.

What is the total number of shares vested?

A total of 726,317 shares were vested under the LTIP.

What positions do Dr. Weiguo Su and Mr. Johnny Cheng hold?

Dr. Su is CEO and CSO, while Mr. Cheng is Acting CEO and CFO.

Last updated: Mar 11, 2026